Monday, March 31, 2014 10:37:39 AM
Like you, just my personal opinion, plus facts:
Patented;
Drug-free;
Side-effect free;
Range of products from muscle, tissue and joint pain to severe menopausal aches and cramping, only a few billion candidates;
FDA proposes new category which will house BIEL application
Inexperienced management made mistakes in the past;
Management has been strengthened by appointment and experience;
Company and management wisely sold shares to stay alive - the challenge and the game.
My motives are two-fold; to make money and see a great product I have used personally approved as an OTC item so I can buy it here in New York.
Another scenario by someone else is only one of two possibles; to try and lower the price to a lower acquisition point, i.e. make money, or out of bitterness, one or the other, but not both.
My hidden agenda? To write of those two baseless motives. Good luck to us both.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM